Coronavirus outbreak: Quick USFDA approvals for asthma drug makers

Cipla gets nod for drug from USFDA earlier than expected; Lupin in fray

The novel coronavirus outbreak may prove to be a shot in the arm for Indian drug exporters to the US as the crisis has resulted in fast-tracking of approvals by the drug regulator there.
 

Cipla, the Indian market leader in respiratory segment, said on Thursday that it received the final approval for its asthma medication albuterol (an inhaler) from the US Food and Drug Administration (USFDA).
 

Cipla's stock touched a 52-week high on Thursday and ended the day's trade on BSE at Rs 579.5 a piece, up 13 per cent from previous close, as the approval for the drug came